Ashland Inc. (ASH) Earnings Call Analysis

NYSE · Basic Materials · Specialty Chemicals

20/25

Growth 4 Margin 3 Expansion 5 Platform 3 Financial 5

latest quarter score

Earnings Reports

20
Ashland (ASH) Q3 2026: 7% Sales Growth as Globalize and Innovate Surpass Annual Targets
July 29, 2026
20
Ashland (ASH) Q2 2026: EBITDA Slips 9% as Operational Setbacks Offset Innovation Surge
April 29, 2026
19
Ashland (ASH) Q1 2026: Specialty Additives Margin Expands 340bps as Innovation Offsets Demand Weakness
February 03, 2026
18
Ashland (ASH) Q4 2025: Portfolio Optimization Drives 110bps Margin Expansion as Cost Actions Take Hold
November 05, 2025
16
Ashland (ASH) Q3 2025: $60M Cost Optimization Set to Unlock Margin Upside Amid Muted Demand
July 30, 2025
11
Ashland (ASH) Q2 2025: Portfolio Optimization Drives 350bps Margin Gain in Personal Care
July 06, 2025
Ashland (ASH) Q4 2024: EBITDA Margin Jumps 950bps as Portfolio Reset Drives Mix Shift
August 07, 2024
Ashland (ASH) Q3 2024: Personal Care Grows 20% as VPND Pharma Share Loss Cuts Outlook
August 07, 2024
Ashland (ASH) Q2 2024: Personal Care Up 30% Sequentially as Demand Normalization Drives Margin Rebound
May 01, 2024
Ashland (ASH) Q1 2024: $136M Inventory Reduction Resets Operating Leverage Ahead of Demand Rebound
January 31, 2024
10
Ashland (ASH) Q4 2023: $200M Portfolio Pruning Targets 250bps Margin Expansion Amid Prolonged Destocking
November 09, 2023
Ashland (ASH) Q3 2023: $1B Buyback and Prolonged Destocking Reset Margin Trajectory
July 26, 2023
Ashland (ASH) Q2 2023: $200M Buyback, Inventory Actions Signal Defensive Shift Amid Destocking Uncertainty
May 03, 2023

Browse all companies